{"nct_id":"NCT00833053","title":"Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)","status":"TERMINATED","status_verified_date":"2017-03","start_date":"2009-10","start_date_type":null,"primary_completion_date":"2011-04","primary_completion_date_type":"ACTUAL","completion_date":"2011-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}